|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:COL4A1-ZNF827 (FusionGDB2 ID:HG1282TG152485) |
Fusion Gene Summary for COL4A1-ZNF827 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: COL4A1-ZNF827 | Fusion gene ID: hg1282tg152485 | Hgene | Tgene | Gene symbol | COL4A1 | ZNF827 | Gene ID | 1282 | 152485 |
| Gene name | collagen type IV alpha 1 chain | zinc finger protein 827 | |
| Synonyms | BSVD|BSVD1|PADMAL|RATOR | - | |
| Cytomap | ('COL4A1')('ZNF827') 13q34 | 4q31.21-q31.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | collagen alpha-1(IV) chainCOL4A1 NC1 domainarrestencollagen IV, alpha-1 polypeptidecollagen of basement membrane, alpha-1 chain | zinc finger protein 827 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P02462 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000375820, ENST00000467182, ENST00000543140, | ||
| Fusion gene scores | * DoF score | 13 X 15 X 8=1560 | 11 X 4 X 7=308 |
| # samples | 15 | 11 | |
| ** MAII score | log2(15/1560*10)=-3.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/308*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: COL4A1 [Title/Abstract] AND ZNF827 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | COL4A1(110801311)-ZNF827(146859787), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | COL4A1-ZNF827 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL4A1-ZNF827 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across COL4A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across ZNF827 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | KIRC | TCGA-BP-4986-01A | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
Top |
Fusion Gene ORF analysis for COL4A1-ZNF827 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000375820 | ENST00000379448 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| 5CDS-intron | ENST00000375820 | ENST00000511534 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| 5CDS-intron | ENST00000375820 | ENST00000513320 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| In-frame | ENST00000375820 | ENST00000508784 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-3CDS | ENST00000467182 | ENST00000508784 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-3CDS | ENST00000543140 | ENST00000508784 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000467182 | ENST00000379448 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000467182 | ENST00000511534 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000467182 | ENST00000513320 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000543140 | ENST00000379448 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000543140 | ENST00000511534 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| intron-intron | ENST00000543140 | ENST00000513320 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000375820 | COL4A1 | chr13 | 110801311 | - | ENST00000508784 | ZNF827 | chr4 | 146859787 | - | 13987 | 6524 | 62 | 5131 | 1689 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000375820 | ENST00000508784 | COL4A1 | chr13 | 110801311 | - | ZNF827 | chr4 | 146859787 | - | 0.000597575 | 0.9994024 |
Top |
Fusion Genomic Features for COL4A1-ZNF827 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
Top |
Fusion Protein Features for COL4A1-ZNF827 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:110801311/chr4:146859787) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| COL4A1 | . |
| FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. {ECO:0000250|UniProtKB:P02463}.; FUNCTION: Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. {ECO:0000269|PubMed:10811134, ECO:0000269|PubMed:18775695}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | COL4A1 | chr13:110801311 | chr4:146859787 | ENST00000375820 | - | 52 | 52 | 1445_1669 | 2134 | 1670.0 | Domain | Collagen IV NC1 |
| Hgene | COL4A1 | chr13:110801311 | chr4:146859787 | ENST00000375820 | - | 52 | 52 | 173_1440 | 2134 | 1670.0 | Region | Note=Triple-helical region |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 311_354 | 0 | 995.0 | Compositional bias | Note=Pro-rich | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 961_972 | 0 | 995.0 | Compositional bias | Note=Poly-Ser | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 311_354 | 14 | 1976.6666666666667 | Compositional bias | Note=Pro-rich | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 961_972 | 14 | 1976.6666666666667 | Compositional bias | Note=Poly-Ser | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 1019_1041 | 0 | 995.0 | Zinc finger | C2H2-type 8 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 1047_1069 | 0 | 995.0 | Zinc finger | C2H2-type 9 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 374_396 | 0 | 995.0 | Zinc finger | C2H2-type 1 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 402_424 | 0 | 995.0 | Zinc finger | C2H2-type 2 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 433_455 | 0 | 995.0 | Zinc finger | C2H2-type 3 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 817_839 | 0 | 995.0 | Zinc finger | C2H2-type 4 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 845_867 | 0 | 995.0 | Zinc finger | C2H2-type 5 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 897_919 | 0 | 995.0 | Zinc finger | C2H2-type 6 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000379448 | 0 | 15 | 929_952 | 0 | 995.0 | Zinc finger | C2H2-type 7 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 1019_1041 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 8 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 1047_1069 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 9 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 374_396 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 1 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 402_424 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 2 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 433_455 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 3 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 817_839 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 4 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 845_867 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 5 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 897_919 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 6 | |
| Tgene | ZNF827 | chr13:110801311 | chr4:146859787 | ENST00000508784 | -1 | 15 | 929_952 | 14 | 1976.6666666666667 | Zinc finger | C2H2-type 7 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for COL4A1-ZNF827 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >18348_18348_1_COL4A1-ZNF827_COL4A1_chr13_110801311_ENST00000375820_ZNF827_chr4_146859787_ENST00000508784_length(transcript)=13987nt_BP=6524nt GCTTGGAGCCGCCGCACCCGGGACGGTGCGTAGCGCTGGAAGTCCGGCCTTCCGAGAGCTAGCTGTCCGCCGCGGCCCCCGCACGCCGGG CAGCCGTCCCTCGCCGCCTCGGGCGCGCCACCATGGGGCCCCGGCTCAGCGTCTGGCTGCTGCTGCTGCCCGCCGCCCTTCTGCTCCACG AGGAGCACAGCCGGGCCGCTGCGAAGGGTGGCTGTGCTGGCTCTGGCTGTGGCAAATGTGACTGCCATGGAGTGAAGGGACAAAAGGGTG AAAGAGGCCTCCCGGGGTTACAAGGTGTCATTGGGTTTCCTGGAATGCAAGGACCTGAGGGGCCACAGGGACCACCAGGACAAAAGGGTG ATACTGGAGAACCAGGACTACCTGGAACAAAAGGGACAAGAGGACCTCCGGGAGCATCTGGCTACCCTGGAAACCCAGGACTTCCCGGAA TTCCTGGCCAAGACGGCCCGCCAGGCCCCCCAGGTATTCCAGGATGCAATGGCACAAAGGGGGAGAGAGGGCCGCTCGGGCCTCCTGGCT TGCCTGGTTTCGCTGGAAATCCCGGACCACCAGGCTTACCAGGGATGAAGGGTGATCCAGGTGAGATACTTGGCCATGTGCCCGGGATGC TGTTGAAAGGTGAAAGAGGATTTCCCGGAATCCCAGGGACTCCAGGCCCACCAGGACTGCCAGGGCTTCAAGGTCCTGTTGGGCCTCCAG GATTTACCGGACCACCAGGTCCCCCAGGCCCTCCCGGCCCTCCAGGTGAAAAGGGACAAATGGGCTTAAGTTTTCAAGGACCAAAAGGTG ACAAGGGTGACCAAGGGGTCAGTGGGCCTCCAGGAGTACCAGGACAAGCTCAAGTTCAAGAAAAAGGAGACTTCGCCACCAAGGGAGAAA AGGGCCAAAAAGGTGAACCTGGATTTCAGGGGATGCCAGGGGTCGGAGAGAAAGGTGAACCCGGAAAACCAGGACCCAGAGGCAAACCCG GAAAAGATGGTGACAAAGGGGAAAAAGGGAGTCCCGGTTTTCCTGGTGAACCCGGGTACCCAGGACTCATAGGCCGCCAGGGCCCGCAGG GAGAAAAGGGTGAAGCAGGTCCTCCTGGCCCACCTGGAATTGTTATAGGCACAGGACCTTTGGGAGAAAAAGGAGAGAGGGGCTACCCTG GAACTCCGGGGCCAAGAGGAGAGCCAGGCCCAAAAGGTTTCCCAGGACTACCAGGCCAACCCGGACCTCCAGGCCTCCCTGTACCTGGGC AGGCTGGTGCCCCTGGCTTCCCTGGTGAAAGAGGAGAAAAAGGTGACCGAGGATTTCCTGGTACATCTCTGCCAGGACCAAGTGGAAGAG ATGGGCTCCCGGGTCCTCCTGGTTCCCCTGGGCCCCCTGGGCAGCCTGGCTACACAAATGGAATTGTGGAATGTCAGCCCGGACCTCCAG GTGACCAGGGTCCTCCTGGAATTCCAGGGCAGCCAGGATTTATAGGCGAAATTGGAGAGAAAGGTCAAAAAGGAGAGAGTTGCCTCATCT GTGATATAGACGGATATCGGGGGCCTCCCGGGCCACAGGGACCCCCGGGAGAAATAGGTTTCCCAGGGCAGCCAGGGGCCAAGGGCGACA GAGGTTTGCCTGGCAGAGATGGTGTTGCAGGAGTGCCAGGCCCTCAAGGTACACCAGGGCTGATAGGCCAGCCAGGAGCCAAGGGGGAGC CTGGTGAGTTTTATTTCGACTTGCGGCTCAAAGGTGACAAAGGAGACCCAGGCTTTCCAGGACAGCCCGGCATGACAGGGAGAGCGGGTT CTCCTGGAAGAGATGGCCATCCGGGTCTTCCTGGCCCCAAGGGCTCGCCGGGTTCTGTAGGATTGAAAGGAGAGCGTGGCCCCCCTGGAG GAGTTGGATTCCCAGGCAGTCGTGGTGACACCGGCCCCCCTGGGCCTCCAGGATATGGTCCTGCTGGTCCCATTGGTGACAAAGGACAAG CAGGCTTTCCTGGAGGCCCTGGATCCCCAGGCCTGCCAGGTCCAAAGGGTGAACCAGGAAAAATTGTTCCTTTACCAGGCCCCCCTGGAG CAGAAGGACTGCCGGGGTCCCCAGGCTTCCCAGGTCCCCAAGGAGACCGAGGCTTTCCCGGAACCCCAGGAAGGCCAGGCCTGCCAGGAG AGAAGGGCGCTGTGGGCCAGCCAGGCATTGGATTTCCAGGGCCCCCCGGCCCCAAAGGTGTTGACGGCTTACCTGGAGACATGGGGCCAC CGGGGACTCCAGGTCGCCCGGGATTTAATGGCTTACCTGGGAACCCAGGTGTGCAGGGCCAGAAGGGAGAGCCTGGAGTTGGTCTACCGG GACTCAAAGGTTTGCCAGGTCTTCCCGGCATTCCTGGCACACCCGGGGAGAAGGGGAGCATTGGGGTACCAGGCGTTCCTGGAGAACATG GAGCGATCGGACCCCCTGGGCTTCAGGGGATCAGAGGTGAACCGGGACCTCCTGGATTGCCAGGCTCCGTGGGGTCTCCAGGAGTTCCAG GAATAGGCCCCCCTGGAGCTAGGGGTCCCCCTGGAGGACAGGGACCACCGGGGTTGTCAGGCCCTCCTGGAATAAAAGGAGAGAAGGGTT TCCCCGGATTCCCTGGACTGGACATGCCGGGCCCTAAAGGAGATAAAGGGGCTCAAGGACTCCCTGGCATAACGGGACAGTCGGGGCTCC CTGGCCTTCCTGGACAGCAGGGGGCTCCTGGGATTCCTGGGTTTCCAGGTTCCAAGGGAGAAATGGGCGTCATGGGGACCCCCGGGCAGC CGGGCTCACCAGGACCAGTGGGTGCTCCTGGATTACCGGGTGAAAAAGGGGACCATGGCTTTCCGGGCTCCTCAGGACCCAGGGGAGACC CTGGCTTGAAAGGTGATAAGGGGGATGTCGGTCTCCCTGGCAAGCCTGGCTCCATGGATAAGGTGGACATGGGCAGCATGAAGGGCCAGA AAGGAGACCAAGGAGAGAAAGGACAAATTGGACCAATTGGTGAGAAGGGATCCCGAGGAGACCCTGGGACCCCAGGAGTGCCTGGAAAGG ACGGGCAGGCAGGACAGCCTGGGCAGCCAGGACCTAAAGGTGATCCAGGTATAAGTGGAACCCCAGGTGCTCCAGGACTTCCGGGACCAA AAGGATCTGTTGGTGGAATGGGCTTGCCAGGAACACCTGGAGAGAAAGGTGTGCCTGGCATCCCTGGCCCACAAGGTTCACCTGGCTTAC CTGGAGACAAAGGTGCAAAAGGAGAGAAAGGGCAGGCAGGCCCACCTGGCATAGGCATCCCAGGGCTGCGAGGTGAAAAGGGAGATCAAG GGATAGCGGGTTTCCCAGGAAGCCCTGGAGAGAAGGGAGAAAAAGGAAGCATTGGGATCCCAGGAATGCCAGGGTCCCCAGGCCTTAAAG GGTCTCCCGGGAGTGTTGGCTATCCAGGAAGTCCTGGGCTACCTGGAGAAAAAGGTGACAAAGGCCTCCCAGGATTGGATGGCATCCCTG GTGTCAAAGGAGAAGCAGGTCTTCCTGGGACTCCTGGCCCCACAGGCCCAGCTGGCCAGAAAGGGGAGCCAGGCAGTGATGGAATCCCGG GGTCAGCAGGAGAGAAGGGTGAACCAGGTCTACCAGGAAGAGGATTCCCAGGGTTTCCAGGGGCCAAAGGAGACAAAGGTTCAAAGGGTG AGGTGGGTTTCCCAGGATTAGCCGGGAGCCCAGGAATTCCTGGATCCAAAGGAGAGCAAGGATTCATGGGTCCTCCGGGGCCCCAGGGAC AGCCGGGGTTACCGGGATCCCCAGGCCATGCCACGGAGGGGCCCAAAGGAGACCGCGGACCTCAGGGCCAGCCTGGCCTGCCAGGACTTC CGGGACCCATGGGGCCTCCAGGGCTTCCTGGGATTGATGGAGTTAAAGGTGACAAAGGAAATCCAGGCTGGCCAGGAGCACCCGGTGTCC CAGGGCCCAAGGGAGACCCTGGATTCCAGGGCATGCCTGGTATTGGTGGCTCTCCAGGAATCACAGGCTCTAAGGGTGATATGGGGCCTC CAGGAGTTCCAGGATTTCAAGGTCCAAAAGGTCTTCCTGGCCTCCAGGGAATTAAAGGTGATCAAGGCGATCAAGGCGTCCCGGGAGCTA AAGGTCTCCCGGGTCCTCCTGGCCCCCCAGGTCCTTACGACATCATCAAAGGGGAGCCCGGGCTCCCTGGTCCTGAGGGCCCCCCAGGGC TGAAAGGGCTTCAGGGACTGCCAGGCCCGAAAGGCCAGCAAGGTGTTACAGGATTGGTGGGTATACCTGGACCTCCAGGTATTCCTGGGT TTGACGGTGCCCCTGGCCAGAAAGGAGAGATGGGACCTGCCGGGCCTACTGGTCCAAGAGGATTTCCAGGTCCACCAGGCCCCGATGGGT TGCCAGGATCCATGGGGCCCCCAGGCACCCCATCTGTTGATCACGGCTTCCTTGTGACCAGGCATAGTCAAACAATAGATGACCCACAGT GTCCTTCTGGGACCAAAATTCTTTACCACGGGTACTCTTTGCTCTACGTGCAAGGCAATGAACGGGCCCATGGCCAGGACTTGGGCACGG CCGGCAGCTGCCTGCGCAAGTTCAGCACAATGCCCTTCCTGTTCTGCAATATTAACAACGTGTGCAACTTTGCATCACGAAATGACTACT CGTACTGGCTGTCCACCCCTGAGCCCATGCCCATGTCAATGGCACCCATCACGGGGGAAAACATAAGACCATTTATTAGTAGGTGTGCTG TGTGTGAGGCGCCTGCCATGGTGATGGCCGTGCACAGCCAGACCATTCAGATCCCACCGTGCCCCAGCGGGTGGTCCTCGCTGTGGATCG GCTACTCTTTTGTGATGCACACCAGCGCTGGTGCAGAAGGCTCTGGCCAAGCCCTGGCGTCCCCCGGCTCCTGCCTGGAGGAGTTTAGAA GTGCGCCATTCATCGAGTGTCACGGCCGTGGGACCTGCAATTACTACGCAAACGCTTACAGCTTTTGGCTCGCCACCATAGAGAGGAGCG AGATGTTCAAGAAGCCTACGCCGTCCACCTTGAAGGCAGGGGAGCTGCGCACGCACGTCAGCCGCTGCCAAGTCTGTATGAGAAGAACAT AATGAAGCCTGACTCAGCTAATGTCACAACATGGTGCTACTTCTTCTTCTTTTTGTTAACAGCAACGAACCCTAGAAATATATCCTGTGT ACCTCACTGTCCAATATGAAAACCGTAAAGTGCCTTATAGGAATTTGCGTAACTAACACACCCTGCTTCATTGACCTCTACTTGCTGAAG GAGAAAAAGACAGCGATAAGCTTTCAATAGTGGCATACCAAATGGCACTTTTGATGAAATAAAATATCAATATTTTCTGCAATCCAATGC ACTGATGTGTGAAGTGAGAACTCCATCAGAAAACCAAAGGGTGCTAGGAGGTGTGGGTGCCTTCCATACTGTTTGCCCATTTTCATTCTT GTATTATAATTAATTTTCTACCCCCAGAGATAAATGTTTGTTTATATCACTGTCTAGCTGTTTCAAAATTTAGGTCCCTTGGTCTGTACA AATAATAGCAATGTAAAAATGGTTTTTTGAACCTCCAAATGGAATTACAGACTCAGTAGCCATATCTTCCAACCCCCCAGTATAAATTTC TGTCTTTCTGCTATGTGTGGTACTTTGCAGCTGCTTTTGCAGAAATCACAATTTTCCTGTGGAATAAAGATGGTCCAAAAATAGTCAAAA ATTAAATATATATATATATTAGTAATTTATATAGATGTCAGCAATTAGGCAGATCAAGGTTTAGTTTAACTTCCACTGTTAAAATAAAGC TTACATAGTTTTCTTCCTTTGAAAGACTGTGCTGTCCTTTAACATAGGTTTTTAAAGACTAGGATATTGAATGTGAAACATCCGTTTTCA TTGTTCACTTCTAAACCAAAAATTATGTGTTGCCAAAACCAAACCCAGGTTCATGAATATGGTGTCTATTATAGTGAAACATGTACTTTG AGCTTATTGTTTTTATTCTGTATTAAATATTTTCAGGGTTTTAAACACTAATCACAAACTGAATGACTTGACTTCAAAAGCAACAACCTT AAAGGCCGTCATTTCATTAGTATTCCTCATTCTGCATCCTGGCTTGAAAAACAGCTCTGTTGAATCACAGTATCAGTATTTTCACACGTA AGCACATTCGGGCCATTTCCGTGGTTTCTCATGAGCTGTGTTCACAGACCTCAGCAGGGCATCGCATGGACCGCAGGAGGGCAGATTCGG ACCACTAGGCCTGAAATGACATTTCACTAAAAGTCTCCAAAACATTTCTAAGACTACTAAGGCCTTTTATGTAATTTCTTTAAATGTGTA TTTCTTAAGAATTCAAATTTGTAATAAAACTATTTGTATAAAAATTAAGCTTTTATTAATTTGTTGCTAGTATTGCCACAGACGCATTAA AAGAAACTTACTGCACAAGCTGCTAATAAATTTGTAAGCTTTGCAAAAAAAAAAAAAGGAAAAAAGAAAGGAAAGAAAAGAAGAAAACCC CTCTTCTGGCTCCAGGAAACAAGCTTCAACCCATTGCACACACCGGAGAAGGGGTTTCCCCCTGCCCGCCCGCCCGCCCCCCAACTACCT CCCCGCTCCTGCCAGTGTCTGCCTCTCTGCCCCCACGGGGGTTTATTTGATCTCACATTAACCAAGGAGGAGAATGTGAGAAAAGGGGGA AAATGCCCAGGAGGAAGCAGGAGCAGCCCAAGCGCCTTCCCTCACATGTTAGTAGGCAGGAAGAGGCGGAGGGAGAGCTCAGTGAAGGAG AACACTGGTATGGAAACTCTTCAGAGACTCCGTCAGAAGCATCCTATGGGGAAGTCCAGGAGAACTATAAGTTGTCTCTGGAGGACCGGA TCCAGGAGCAGTCCACGTCCCCGGACACCTCCTTGGGAAGCACGACTCCCAGCAGCCACACGTTGGAGCTGGTGGCACTGGACAGTGAGG TCCTGCGAGACTCACTGCAGTGTCAAGATCACCTTTCCCCGGGAGTGTCTTCTTTGTGTGACGATGACCCAGGCTCCAACAAGCCCCTGA GCAGCAATTTGAGGCGGCTGCTGGAGGCTGGTTCCCTCAAACTCGATGCTGCAGCCACGGCTAATGGCAGAGTGGAGTCCCCCGTAAACG TTGGCTCGAACCTCTCCTTTTCCCCGCCTTCCCACCACGCCCAGCAGCTCAGTGTTCTGGCCAGGAAGTTGGCCGAGAAGCAGGAACAGA ATGACCAATACACTCCAAGTAACCGTTTTATATGGAATCAAGGTAAGTGGTTGCCAAACTCAACCACCACCTGCAGCTTGTCTCCGGATT CAGCCATCCTAAAACTGAAAGCTGCAGCCAATGCCGTTCTGCAGGACAAATCTCTCACCAGGACTGAGGAGACCATGCGATTTGAGTCCT TTTCCTCCCCTTTTAGCTCCCAGTCTGCCAGTTCTACCTTGGCCGCTTTGTCCAAGAAGGTCAGTGAAAGAAGTTTGACTCCTGGTCAGG AGCACCCTCCACCGGCCAGCTCCTTCCTTTCCCTGGCTTCTATGACCTCCTCAGCGGCCCTTCTGAAGGAGGTGGCCGCAAGGGCTGCGG GCAGTCTTCTGGCTGAGAAATCATCGCTGCTGCCTGAGGACCCTCTACCGCCCCCGCCTTCAGAGAAGAAACCAGAAAAAGTCACTCCGC CACCTCCACCGCCACCTCCACCACCTCCACCACCACCACCACAATCCCTGGAATTATTATTACTCCCAGTTCCTAAGGGAAGAGTTTCTA AACCCTCCAATTCAGCCTCAGAAGAGGAAAGTGGAAAGCCTTTCCAGTGTCCAATATGTGGTTTGGTTATTAAAAGGAAGAGTTACTGGA AGCGGCACATGGTGATTCACACAGGTTTAAAAAGTCATCAGTGTCCGCTCTGTCCATTCCGGTGTGCTCGCAAGGACAATCTCAAATCCC ACATGAAGGTTCATCAGCACCAGGATCGGGGAGAGACCTTTCAGTGCCAGCTGTGCCCTTTTACTTCCTCACGCCACTTCAGCCTGAAAC TCCACATGCGTTGCCATCAGCACTTCCTGAGGACAGAAGCCAAGGTGAAGGAGGAGATCCCAGACCCAGATGTCAAGGGATCTCCCCACC TCAGTGACAGTGCCTGCCTGGGGCAGCAAAGGGAAGGAGGAGGGACAGAGCTAGTGGGGACCATGATGACGTCTAACACTCCAGAGAGGA CTAGCCAGGGAGGGGCTGGCGTCTCGCCTTTGCTGGTGAAGGAGGAACCCAAGGAAGATAACGGCCTGCCCACCTCCTTTACTTTGAATG CTGCCGACAGGCCCGCCAACCACACAAAGCTGAAAGACCCCTCCGAGTATGTGGCCAACAGTGCGTCAGCATTGTTCAGCCAGGACATCT CTGTTAAGATGGCGTCTGATTTTCTCATGAAGCTGTCAGCTGCAAATCAGAAGGAGCCCATGAATCTTAATTTTAAAGTGAAAGAGGAGC CTAAGGAAGGGGAGTCCCTAAGCACGACTTTGCCTCGGTCCAGCTATGTGTTCAGCCCGGAATCTGAAGTGTCAGCCCCAGGCGTCTCTG AGGACGCACTAAAGCCCCAGGAAGGGAAGGGAAGTGTGCTAAGGCGGGATGTGTCAGTCAAAGCAGCCTCTGAACTTCTCATGAAACTCT CAGCGGAAAGCTACAAGGAAACACAGATGGTGAAGATTAAAGAGGAACCCATGGAGGTTGACATCCAGGACTCCCATGTCTCGATATCAC CCAGCCGGAATGTTGGCTACAGCACTTTAATCGGGCGAGAGAAAACCGAACCCTTACAGAAGATGCCAGAGGGCAGAGTACCCCCAGAGA GAAACCTCTTCAGTCAGGATATCTCTGTGAAAATGGCTTCCGAGCTCCTCTTTCAACTGTCAGAAAAAGTGAGCAAAGAGCACAATCATA CAAAAGAAAACACCATCCGGACCACGACCAGCCCTTTCTTTTCAGAAGACACATTTAGACAATCACCATTCACCTCCAATTCAAAAGAAC TGCTGCCCAGTGACTCCGTGCTGCACGGAAGAATATCAGCTCCAGAAACAGAAAAGATAGTCCTAGAGGCAGGAAATGGATTACCATCCT GGAAATTCAATGACCAGCTTTTTCCCTGTGACGTGTGTGGGAAAGTGTTTGGCCGACAGCAGACATTGTCCCGACACCTCTCGCTGCACA CAGAGGAAAGAAAATACAAATGCCACTTGTGCCCCTATGCTGCTAAGTGCCGTGCAAATCTGAACCAGCACTTGACCGTCCATTCCGTGA AGCTGGTGAGTACAGACACCGAGGACATTGTCAGCGCCGTCACCTCTGAAGGCAGTGATGGGAAGAAACATCCTTATTATTACAGTTGTC ACGTGTGTGGATTTGAGACCGAGCTCAATGTCCAGTTTGTCAGCCACATGTCACTCCACGTGGACAAGGAGCAGTGGATGTTTTCGATCT GCTGCACTGCCTGCGACTTCGTCACCATGGAGGAAGCAGAGATAAAGACTCACATTGGCACCAAGCACACAGGGGAAGACAGGAAGACCC CCAGCGAATCAAATAGCCCCTCTTCATCCTCCCTCTCAGCTCTGAGTGATTCAGCCAACAGCAAAGATGATTCAGATGGCTCCCAGAAAA ACAAGGGCGGGAACAATCTGCTGGTCATCTCTGTCATGCCTGGGAGCCAGCCCTCACTGAACAGTGAGGAAAAGCCAGAGAAAGGGTTCG AATGTGTTTTTTGCAACTTTGTCTGCAAGACGAAGAACATGTTTGAGCGTCATCTGCAGATACACCTCATCACCCGGATGTTTGAGTGTG ATGTGTGCCACAAGTTCATGAAGACCCCCGAACAGCTGCTGGAGCATAAGAAATGCCACACTGTCCCCACCGGTGGGCTCAACTCAGGAC AGTGGTGAGTTTCAGACTCCTCTAGGTGCCCATTCTGCATTTATTCCACCAACCGCCCCGCTGCCATGGAGTGCCACCTCAAGACCCACT ACAAGATGGAGTACAAGTGCCGGATCTGCCAGACGGTGAAGGCCAACCAGCTGGAGCTGGAGACGCACACCCGGGAGCACCGCCTGGGCA ACCACTACAAGTGCGACCAGTGCGGCTACCTGTCCAAGACCGCCAACAAGCTCATCGAGCACGTGCGCGTCCACACCGGGGAGCGGCCCT TCCACTGTGACCAGTGCAGCTACAGCTGCAAGCGCAAGGACAATCTCAACCTGCACAAGAAGCTGAAGCACGCCCCACGCCAGACCTTCA GCTGCGAAGAGTGCCTGTTCAAGACCACACACCCTTTCGTCTTCAGCCGCCACGTCAAGAAGCACCAGAGTGGGGACTGCCCCGAGGAGG ACAAGAAGGGCCTGTGTCCAGCCCCCAAGGAACCGGCCGGCCCGGGGGCCCCGCTCCTGGTGGTCGGGAGCTCCCGGAATCTCCTGTCTC CCCTGTCAGTTATGTCTGCCTCCCAGGCTCTGCAGACCGTGGCCCTGTCGGCAGCCCACGGCAGCAGCTCAGAGCCCAACCTGGCACTCA AGGCTTTGGCCTTCAACGGCTCCCCTTTGCGCTTTGACAAGTACCGGAACTCAGATTTTGCCCATCTCATTCCCTTGACAATGTTATACC CCAAGAACCACTTGGATCTCACATTCCACCCTCCCCGACCTCAGACTGCGCCTCCCAGCATCCCCTCACCCAAACACTCCTTCCTGGCCT ATCTCGGACTGAGAGAAAGAGCAGAGACTGTCTGAGGGCAGCCATGTTCTGTACCAAAAACAGAGAGACAAAAGACAAAAAAAAAAAAAA AAACCACAAAACTTAAACACAACCCCAGCAGGTGTATGTTGCTGCAAAACCTACAGACCCCGATGGGTCTGGAACATGTGTACTGTATAT CTTTAGTAAGGAATAGAAAATTGGCTCTGTGTGTATACCTATTGCATTGACCTGAAAGCTGCTTTATCCAATCTTCAGAGAGGTGACCTA CTGCATACTTCTACCTTCAGAGGCATGCCTCCCCAGCCACCCACTCCCACTCTCAGCCCTTCTCCGTACTTTTCTCTGAAAGGAATCTTG TCTTGTTAAACCCTAAAGAGAGTGTCCTTAATAGCAATCAGCACTTGTAAGCTTATATACTGGTGCATTTGGTTTTCTGTTGGGTGAATG CGGTGTGTGGGCGTTTGTGGATTCTGAAAGAGAAAGCCGTGTGTCGTGTGCCATGACATTTCTATTGCACATTCTTTGTACTGGCTTCTT TAACAGCGATGAACGTTCTTTTCCCTCCTGGGTTGTTCATCCACGACAGTCTCTCCCTGTGCTCCTTCATCACCTTTCCCTCTCTCTTTG ATGGCTACAGAGTGGTAGGGCCTGGTGCTTAGTCGATGAAGGAATGGTAGCCATCTACAGTGCTGCTGGAGATTTCCGCCAGAGCGCTGG AGACCTTGCGCTCAGATCTTCTCTGGTGATGAAGAGGCGAGGAATCAAGTGACTGATCTGGAAGAAATATCTCGCAGCACTGCAGCTAAC ATCACAGAACTTAAGTGTGTTTTGTGTGTGTGCCCACACGTAGACAAATGTGTACGGTGCACACACACAGTGCATCATTTTTTAAGGGCA GATTATATATATATATGAGATGTATTAATTCAGTGGTTACCATTTGTTTGCAGGAAAAAGAAATGTATGGGTGAAAAAATTTATGGTTGA TAAATCCAGCCAAGGAGATTAAAAGGGGTTTGGATAAATTCTGGGTATAAATGCTCAGACTAAAAAAAAGAAATGGCAGTTTTGCACAGT GCTATGGTCTTGCACTAGTTTTTGTTTCTCATCTGAAAAAAAAAAAGTAAAATAAAAGGAAGAAAATGTACCTTTTTTATGGAATGAGTA GACTGTATGTTTGAAGATTTAGCCACAACCTCTTTGACATATAATGACGCAACAAAAAGGTGCTGTTTAGTCCTATGGTTCAGTTTATGC CCCTGACAAGTTTCCATTGTGTTTTGCCGATCTTCTGGCTAATCGTGGTATCCTCCATGTTATTAGTAATTCTGTATTCCATTTTGTTAA CGCCTGGTAGATGTAACCTGCTAGGAGGCTAACTTTATACTTATTTAAAAGCTCTTATTTTGTGGTCATTAAAATGGCAATTTATGTGCA GCACTTTATTGCAGCAGGAAGCAGGTGTGGGTTGGTTGTAAAGCTCTTTGCTAATCTTAAAAAGTAATGGGTGATTTAAAAAGAAAAAAG GAAAAAAATCTTTGGCTGAATATGTTCATTGCTTGTATTTTTAAAACAACAGAATTTCCAGTATGAAACAGGCTGAAAGAGCAGGAAGAA ATGTTCTTTGTATAATAATGGGAAGTTTGGAATATAAAAGTTTATATATTATTTATCTATTGGAGAACTGGTGTACAGGAGGAACATTTT CTTACTGTGTTGCTGTTTTCCATCATGTGTTATCCTAAGAGTTGGGGTTTTTTAAAATCTGTTTCACCAGGGGAAAATAAAAGCATCCCT AATGTTCTTCCTCTAGTCAGTTTGCTTTGCTGAAAGCTCCCTGGAAATTAGTACAGTTCTACAGGAAGCCAGAAGACTGTACTGTCTGTC CACACCATGGTCTCCTCAGTCCCCTCCACGCCAGCCCCTCTTCCCCACACCTAGTAGGTGTGCTACACCTCCCTTTGCCAGTCATCCCGC CATGGATGGGGAGCCTACTTGGTGCCCTGGCAAACCTGTTTACACTAAGGAGATGCCCACAGGGAGCGGGAAGCTCCCAAACCCTCAGTC ATTCTCCAGCAGAGACCTTTGCTCTTGGCCAGGTTTGAAACGATGTTCAACCTCGCCACGTCAATGTCTCAGTAAAAGACACTATAGATA GTTATGGACAATACACTCCAAGAATACTGGGCTTATGGGTGGGTTGGTTTTTTGTTTTGTTTTGTTTTGTTTTCAAGTCATGTCTTTATC CCCATATAATGGAGAATGTGCCACTTGGCTAATAATGTGTTTTCAAAACTACAAGTTCAGTGATGACAGGAAAGAGGGCTAAAGTAGTCC CACAGAGGCTGGTAGAAAAGGCGAATCACACTTAAGCACCAGCAGGTTAAAAACCTGAAAGGGTGGCCCTGACAATTCAGACTATAGGTT TTACAGCATGCCACTTGTGCAATAGGAGGTCTAGGGTTGAAACTTTCAAGAACGAGAGGAGGTGAAGGAAGGAGACGTTTACTGCTCAAA TGCCATGCATTTCACTGCTTGCCACTGAACTTGTATTTGAATGACTTAGTAATGCTTAATATAATTGGGCAACTTTTTTAGCACTTTGGA AAGAGTCATCAATCTTTCTGGTAAATTATAAAAGTTTTCTGAGTGAGAAAAGGTGTGTTTGGAGTTTGTTTGACTTTTTATATTATTATT GTTATTAATAAAGAAAAAAATCTACAGCATTTTTCAGACTCCACCCTAGAAAATATGTACCCCTGAATTTGGTTTGCAGTTTGATACTCA GGGAAGGATGTATTCCATAGATATCCTTTCCGTATAAAACACTAACATCTTTGAGAAATTCACCTACCAACTAACTTCAATTGTTGTCAC TATGCATTCTTCAATGAAAACTAGCTTATTTTTCCATATAGTAATGCAGTTAGGGTTCTCAGCACTTTCTTTCTTCTATCCTTTTTTTAA CTCTTCATATTATGTTCAGATGATCATACTGTCAAGGTTTGTGTACATTACTGAAAATTTGTATTGTATAAAGCTTTTTGCATTACGAGG CTGTACAGGGTCATTTTGACAGTAACTGGTATATTCCTTTGCATCTTATGTTGCATTGCCAATTTCTAGTGTATCCAGTTTGAAAGTATA ATATACTCTAATTAAAAAAAAAAAAAGGTTGGCTATA >18348_18348_1_COL4A1-ZNF827_COL4A1_chr13_110801311_ENST00000375820_ZNF827_chr4_146859787_ENST00000508784_length(amino acids)=1689AA_BP= MSAAAPARRAAVPRRLGRATMGPRLSVWLLLLPAALLLHEEHSRAAAKGGCAGSGCGKCDCHGVKGQKGERGLPGLQGVIGFPGMQGPEG PQGPPGQKGDTGEPGLPGTKGTRGPPGASGYPGNPGLPGIPGQDGPPGPPGIPGCNGTKGERGPLGPPGLPGFAGNPGPPGLPGMKGDPG EILGHVPGMLLKGERGFPGIPGTPGPPGLPGLQGPVGPPGFTGPPGPPGPPGPPGEKGQMGLSFQGPKGDKGDQGVSGPPGVPGQAQVQE KGDFATKGEKGQKGEPGFQGMPGVGEKGEPGKPGPRGKPGKDGDKGEKGSPGFPGEPGYPGLIGRQGPQGEKGEAGPPGPPGIVIGTGPL GEKGERGYPGTPGPRGEPGPKGFPGLPGQPGPPGLPVPGQAGAPGFPGERGEKGDRGFPGTSLPGPSGRDGLPGPPGSPGPPGQPGYTNG IVECQPGPPGDQGPPGIPGQPGFIGEIGEKGQKGESCLICDIDGYRGPPGPQGPPGEIGFPGQPGAKGDRGLPGRDGVAGVPGPQGTPGL IGQPGAKGEPGEFYFDLRLKGDKGDPGFPGQPGMTGRAGSPGRDGHPGLPGPKGSPGSVGLKGERGPPGGVGFPGSRGDTGPPGPPGYGP AGPIGDKGQAGFPGGPGSPGLPGPKGEPGKIVPLPGPPGAEGLPGSPGFPGPQGDRGFPGTPGRPGLPGEKGAVGQPGIGFPGPPGPKGV DGLPGDMGPPGTPGRPGFNGLPGNPGVQGQKGEPGVGLPGLKGLPGLPGIPGTPGEKGSIGVPGVPGEHGAIGPPGLQGIRGEPGPPGLP GSVGSPGVPGIGPPGARGPPGGQGPPGLSGPPGIKGEKGFPGFPGLDMPGPKGDKGAQGLPGITGQSGLPGLPGQQGAPGIPGFPGSKGE MGVMGTPGQPGSPGPVGAPGLPGEKGDHGFPGSSGPRGDPGLKGDKGDVGLPGKPGSMDKVDMGSMKGQKGDQGEKGQIGPIGEKGSRGD PGTPGVPGKDGQAGQPGQPGPKGDPGISGTPGAPGLPGPKGSVGGMGLPGTPGEKGVPGIPGPQGSPGLPGDKGAKGEKGQAGPPGIGIP GLRGEKGDQGIAGFPGSPGEKGEKGSIGIPGMPGSPGLKGSPGSVGYPGSPGLPGEKGDKGLPGLDGIPGVKGEAGLPGTPGPTGPAGQK GEPGSDGIPGSAGEKGEPGLPGRGFPGFPGAKGDKGSKGEVGFPGLAGSPGIPGSKGEQGFMGPPGPQGQPGLPGSPGHATEGPKGDRGP QGQPGLPGLPGPMGPPGLPGIDGVKGDKGNPGWPGAPGVPGPKGDPGFQGMPGIGGSPGITGSKGDMGPPGVPGFQGPKGLPGLQGIKGD QGDQGVPGAKGLPGPPGPPGPYDIIKGEPGLPGPEGPPGLKGLQGLPGPKGQQGVTGLVGIPGPPGIPGFDGAPGQKGEMGPAGPTGPRG FPGPPGPDGLPGSMGPPGTPSVDHGFLVTRHSQTIDDPQCPSGTKILYHGYSLLYVQGNERAHGQDLGTAGSCLRKFSTMPFLFCNINNV CNFASRNDYSYWLSTPEPMPMSMAPITGENIRPFISRCAVCEAPAMVMAVHSQTIQIPPCPSGWSSLWIGYSFVMHTSAGAEGSGQALAS PGSCLEEFRSAPFIECHGRGTCNYYANAYSFWLATIERSEMFKKPTPSTLKAGELRTHVSRCQVCMRRT -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for COL4A1-ZNF827 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for COL4A1-ZNF827 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for COL4A1-ZNF827 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | COL4A1 | C4551998 | Porencephaly, Type 1, Autosomal Dominant | 18 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | COL4A1 | C2673195 | Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | COL4A1 | C1843512 | BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Hgene | COL4A1 | C0018965 | Hematuria | 3 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0266548 | Axenfeld anomaly (disorder) | 3 | CTD_human;GENOMICS_ENGLAND |
| Hgene | COL4A1 | C1860475 | Retinal vascular tortuosity | 3 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0011881 | Diabetic Nephropathy | 2 | CTD_human |
| Hgene | COL4A1 | C0017667 | Nodular glomerulosclerosis | 2 | CTD_human |
| Hgene | COL4A1 | C0017668 | Focal glomerulosclerosis | 2 | CTD_human |
| Hgene | COL4A1 | C0086432 | Hyalinosis, Segmental Glomerular | 2 | CTD_human |
| Hgene | COL4A1 | C0265341 | Rieger syndrome | 2 | CTD_human |
| Hgene | COL4A1 | C0266484 | Schizencephaly | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | COL4A1 | C0302892 | Congenital porencephaly | 2 | CTD_human |
| Hgene | COL4A1 | C1280768 | Axenfeld syndrome | 2 | CTD_human |
| Hgene | COL4A1 | C1867983 | PORENCEPHALY, FAMILIAL | 2 | CTD_human;ORPHANET |
| Hgene | COL4A1 | C2675650 | Brain Small Vessel Disease With Axenfeld-Rieger Anomaly | 2 | CTD_human |
| Hgene | COL4A1 | C2678503 | AXENFELD-RIEGER SYNDROME, TYPE 3 | 2 | CTD_human |
| Hgene | COL4A1 | C3281105 | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2 | GENOMICS_ENGLAND;UNIPROT |
| Hgene | COL4A1 | C3495488 | Axenfeld-Rieger syndrome | 2 | CTD_human |
| Hgene | COL4A1 | C3698507 | Post-traumatic Porencephaly | 2 | CTD_human |
| Hgene | COL4A1 | C3714873 | Axenfeld-Rieger Syndrome, Type 1 | 2 | CTD_human |
| Hgene | COL4A1 | C4082173 | Porencephaly | 2 | CTD_human |
| Hgene | COL4A1 | C4082301 | Developmental Porencephaly | 2 | CTD_human |
| Hgene | COL4A1 | C0002878 | Anemia, Hemolytic | 1 | CTD_human |
| Hgene | COL4A1 | C0002879 | Anemia, Hemolytic, Acquired | 1 | CTD_human |
| Hgene | COL4A1 | C0002889 | Anemia, Microangiopathic | 1 | CTD_human |
| Hgene | COL4A1 | C0015393 | Eye Abnormalities | 1 | CTD_human |
| Hgene | COL4A1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | COL4A1 | C0026848 | Myopathy | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Hgene | COL4A1 | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0038454 | Cerebrovascular accident | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0149931 | Migraine Disorders | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0221021 | Microangiopathic hemolytic anemia | 1 | CTD_human |
| Hgene | COL4A1 | C0265221 | Walker-Warburg congenital muscular dystrophy | 1 | ORPHANET |
| Hgene | COL4A1 | C0270612 | Leukoencephalopathy | 1 | CTD_human |
| Hgene | COL4A1 | C0338656 | Impaired cognition | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0497327 | Dementia | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C1135196 | Heart Failure, Diastolic | 1 | CTD_human |
| Hgene | COL4A1 | C1858991 | Childhood Ataxia with Central Nervous System Hypomyelinization | 1 | CTD_human |
| Hgene | COL4A1 | C1867327 | RETINAL ARTERIES, TORTUOSITY OF | 1 | CTD_human;ORPHANET;UNIPROT |
| Hgene | COL4A1 | C2733158 | Cerebral Small Vessel Diseases | 1 | GENOMICS_ENGLAND |
| Hgene | COL4A1 | C2930808 | Familial vascular leukoencephalopathy | 1 | ORPHANET |
| Hgene | COL4A1 | C2931870 | Familial schizencephaly | 1 | ORPHANET |
| Hgene | COL4A1 | C4013035 | BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies